Cisplatin and 5-Fluorouracil with or Without Epidermal Growth Factor Receptor Inhibition Panitumumab for Patients with Non-Resectable, Advanced or Metastatic Esophageal Squamous Cell Cancer: A Prospective, Open-Label, Randomised Phase 3 AIO/EORTC Trial (Power)

Growth Factor ◽

Epidermal Growth Factor ◽

Squamous Cell Cancer ◽

Cell Cancer ◽

Growth Factor Receptor ◽

Open Label ◽

Phase 3 ◽

Receptor Inhibition ◽

Cisplatin and 5-fluorouracil with or without epidermal growth factor receptor inhibition panitumumab for patients with non-resectable, advanced or metastatic oesophageal squamous cell cancer: a prospective, open-label, randomised phase III AIO/EORTC trial (POWER)

Annals of Oncology ◽

10.1016/j.annonc.2019.10.018 ◽

2020 ◽

Vol 31 (2) ◽

pp. 228-235 ◽

Cited By ~ 7

Author(s):

M. Moehler ◽

A. Maderer ◽

P.C. Thuss-Patience ◽

B. Brenner ◽

J. Meiler ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Squamous Cell Cancer ◽

Cell Cancer ◽

Growth Factor Receptor ◽

Phase Iii ◽

Open Label ◽

Receptor Inhibition ◽

Locally Advanced Squamous Cell Cancer of the Head and Neck — Targeting Epidermal Growth Factor Receptor

European Oncology & Haematology ◽

10.17925/eoh.2007.0.2.41 ◽

2007 ◽

Vol 00 (02) ◽

pp. 41

Author(s):

Rainald Knecht ◽

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Head And Neck ◽

Squamous Cell ◽

Squamous Cell Cancer ◽

Cell Cancer ◽

Locally Advanced ◽

Growth Factor Receptor ◽

Analysis of epidermal growth factor receptor (EGFR) pathway in oropharyngeal squamous cell cancer patients in vivo (OSCC)

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.5518 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 5518-5518

Author(s):

A. Psyrri ◽

Z. Yu ◽

B. Haffty ◽

C. Sasaki ◽

P. Weinberger ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Cancer Patients ◽

Squamous Cell ◽

Squamous Cell Cancer ◽

Cell Cancer ◽

Growth Factor Receptor ◽

Expression of epidermal growth factor receptor and vascular endothelial growth factor in vaginal squamous cell cancer

American Journal of Obstetrics and Gynecology ◽

10.1016/j.ajog.2010.09.031 ◽

2011 ◽

Vol 204 (2) ◽

pp. 171.e1-171.e6 ◽

Cited By ~ 1

Author(s):

Andreas Brunner ◽

Christoph Grimm ◽

Stephan Polterauer ◽

Lukas Hefler ◽

Josefine Stani ◽

...

Keyword(s):

Vascular Endothelial Growth Factor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Squamous Cell Cancer ◽

Cell Cancer ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Epidermal Growth ◽

Endothelial Growth Factor

Abstract GS1-09: Addition of S-1 to endocrine therapy in the post-operative adjuvant treatment of hormone receptor-positive and human epidermal growth factor receptor 2-negative primary breast cancer: A multicenter, open-label, phase 3 randomized trial (POTENT trial)

10.1158/1538-7445.sabcs19-gs1-09 ◽

2020 ◽

Author(s):

Masakazu Toi ◽

Shigeru Imoto ◽

Takanori Ishida ◽

Yoshinori Ito ◽

Hiroji Iwata ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Open Label ◽

Phase 3 ◽

Hormone Receptor Positive ◽

Open Label Phase ◽

Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer

European Journal of Cancer ◽

10.1016/j.ejca.2018.04.004 ◽

2018 ◽

Vol 97 ◽

pp. 7-15 ◽

Cited By ~ 9

Author(s):

S. Cavalieri ◽

F. Perrone ◽

R. Miceli ◽

P.A. Ascierto ◽

L.D. Locati ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Squamous Cell Cancer ◽

Cell Cancer ◽

Single Agent ◽

Locally Advanced ◽

Growth Factor Receptor ◽

Efficacy And Safety ◽

Combined hedgehog and epidermal growth factor receptor (EGFR) inhibition in a direct patient tumor model (DPTM) of head and neck squamous cell cancer (HNSCC).

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.5558 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 5558-5558 ◽

Cited By ~ 5

Author(s):

S. Keysar ◽

R. Anderson ◽

S. Takimoto ◽

A. Tan ◽

I. Deyneko ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Squamous Cell Cancer ◽

Cell Cancer ◽

Growth Factor Receptor ◽

Tumor Model ◽

Egfr Inhibition ◽

Epidermal Growth ◽

Neck Squamous Cell Cancer

Expression of epidermal growth factor receptor (EGFR) and number of EGFR gene copy in head and neck squamous cell cancer

HNO-Informationen (Kongressabstracts) ◽

10.1055/s-2005-869168 ◽

2005 ◽

Vol 84 (01) ◽

Author(s):

J Plzak ◽

J Betka ◽

M Mrhalova ◽

R Kodet

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Squamous Cell Cancer ◽

Cell Cancer ◽

Growth Factor Receptor ◽

Gene Copy ◽

Egfr Gene ◽

Epidermal Growth ◽

Neck Squamous Cell Cancer

Epidermal growth factor receptor variant III mutation in Chinese patients with squamous cell cancer of the lung

Thoracic Cancer ◽

10.1111/1759-7714.12204 ◽

2015 ◽

Vol 6 (3) ◽

pp. 319-326 ◽

Cited By ~ 3

Author(s):

Jianchun Duan ◽

Zhijie Wang ◽

Hua Bai ◽

Tongtong An ◽

Minglei Zhuo ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Squamous Cell ◽

Squamous Cell Cancer ◽

Cell Cancer ◽

Growth Factor Receptor ◽

Chinese Patients ◽

Epidermal Growth ◽

Cancer Of The Lung

Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial

The Lancet Oncology ◽

10.1016/s1470-2045(09)70364-x ◽

2010 ◽

Vol 11 (2) ◽

pp. 121-128 ◽

Cited By ~ 2470

Author(s):

Tetsuya Mitsudomi ◽

Satoshi Morita ◽

Yasushi Yatabe ◽

Shunichi Negoro ◽

Isamu Okamoto ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Open Label ◽

Phase 3 ◽